Ziccum CEO Ann Gidner gave a compelling presentation at Stora Aktiedagarna, Stockholm on 27th of November showcasing Ziccum’s groundbreaking LaminarPace technology, which transforms fragile liquid biologics into robust, thermostable dry powders while preserving drug activity and significantly reducing costs. This innovation is paving the way for a new era in the biopharmaceutical industry by eliminating the need for cold chain and enabling new drug delivery forms possible.
Don’t miss the chance to watch the presentation (in Swedish): https://youtu.be/B3iFEhtsAkE